These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20837329)

  • 1. The role of HLA in umbilical cord blood transplantation.
    Delaney M; Ballen KK
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):179-87. PubMed ID: 20837329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
    Cornetta K; Laughlin M; Carter S; Wall D; Weinthal J; Delaney C; Wagner J; Sweetman R; McCarthy P; Chao N
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):149-60. PubMed ID: 15682076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.
    Rocha V; Gluckman E;
    Br J Haematol; 2009 Oct; 147(2):262-74. PubMed ID: 19796275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.
    Kamani N; Spellman S; Hurley CK; Barker JN; Smith FO; Oudshoorn M; Bray R; Smith A; Williams TM; Logan B; Eapen M; Anasetti C; Setterholm M; Confer DL;
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):1-6. PubMed ID: 18158954
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
    Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
    Gluckman E; Rocha V; Arcese W; Michel G; Sanz G; Chan KW; Takahashi TA; Ortega J; Filipovich A; Locatelli F; Asano S; Fagioli F; Vowels M; Sirvent A; Laporte JP; Tiedemann K; Amadori S; Abecassis M; Bordigoni P; Diez B; Shaw PJ; Vora A; Caniglia M; Garnier F; Ionescu I; Garcia J; Koegler G; Rebulla P; Chevret S;
    Exp Hematol; 2004 Apr; 32(4):397-407. PubMed ID: 15050751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion of umbilical cord blood for transplantation.
    Tung SS; Parmar S; Robinson SN; De Lima M; Shpall EJ
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):245-57. PubMed ID: 20837337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood transplantation in children with haematological malignancies.
    Bertaina A; Bernardo ME; Caniglia M; Vinti L; Giorgiani G; Locatelli F
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):189-96. PubMed ID: 20837330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the role of umbilical cord blood transplantation.
    Brunstein CG; Setubal DC; Wagner JE
    Br J Haematol; 2007 Apr; 137(1):20-35. PubMed ID: 17359369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukaemia and myelodysplastic syndromes.
    Sebrango A; Vicuña I; de Laiglesia A; Millán I; Bautista G; Martín-Donaire T; Regidor C; Cabrera R; Fernandez MN
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):259-74. PubMed ID: 20837338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of HLA matching and the outcome of unrelated umbilical cord blood transplantation (CBT).
    Shi-xia X; Xian-hua T; Hai-qin X; Bo F; Hai-qing C; Xiang-Feng T
    Transpl Immunol; 2009 Sep; 21(4):234-9. PubMed ID: 19481604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
    Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
    Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
    Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
    Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of cord blood transplantation: from bench to bedside.
    Gluckman E
    Br J Haematol; 2009 Oct; 147(2):192-9. PubMed ID: 19796268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
    Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
    Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.